Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Metabolism: Clinical and Experimental|April 1, 1982
Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the betablocker pindololH Schiffl, P Weidmann, R Mordasini, et al.
Journal of Nephrology|December 4, 2001
Reversible MRI changes in a patient with uremic encephalopathyM Schmidt, T Sitter, S R Lederer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMPF Lauster, R Gerzer, J Weil, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Extracorporeal antibody elimination in neuroimmunological diseasesM Toepfer, H Schiffl, T Sitter, et al.
European Journal of Medical Research|April 6, 2011
Lung function in adult patients with cystic fibrosis after using the eFlow rapid for one yearSusanne Naehrig, S Lang, H Schiffl, et al.
Deutsche Medizinische Wochenschrift (1946)|July 6, 1990
[The quality of life of older patients under the conditions of long-term dialysis]S Schnack, J Eigler, H Schiffl, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: effects on blood pressure, endocrine function, sodium and plasma volumeM Grimm, P Weidmann, A Meier, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 1, 1997
Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patientsM Goedde, T Sitter, H Schiffl, et al.
The American Journal of Physiology|November 1, 1996
Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediatorsT Sitter, K Toet, H Fricke, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Beta-receptor-blocking agents may reverse or prevent diuretic-induced increases in serum low-density lipoprotein cholesterolA Meier, H Schiffl, P Weidmann, et al.
Pageof 13